CIK 0001680367 · Non-accelerated filer<br>Smaller reporting company
Shattuck Labs, Inc.
Sign in to watch- Ticker
- STTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812575858
- Phone
- 512-900-4690
- Business address
- 500 W. 5TH STREET, AUSTIN, TX, 78701
- Former names
- Shattuck Labs, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-25 | SIEGALL CLAY B Director | Grant or award | +128,054 | $0.87 | $111K | 128,054 |
| 2025-08-25 | SIEGALL CLAY B Director | Grant or award · Warrants (Right to Buy) | +128,054 | 128,054 | ||
| 2025-08-25 | Shukla Abhinav A. Chief Technical Officer | Grant or award | +5,122 | $0.87 | $4K | 81,258 |
| 2025-08-25 | Shukla Abhinav A. Chief Technical Officer | Grant or award · Warrants (Right to Buy) | +5,122 | 5,122 | ||
| 2025-08-25 | Redmile Group, LLC Director | Grant or award · Pre-Funded Warrants to Purchase Common Stock | +4,097,730 | 7,198,553 | ||
| 2025-08-25 | Redmile Group, LLC Director | Grant or award · Common Warrants to Purchase Common Stock | +4,097,730 | 4,097,730 | ||
| 2025-07-14 | Lee Michael Stewart Director | Grant or award · Stock Option (Right to Buy) | +33,150 | 33,150 | ||
| 2025-07-14 | Redmile Group, LLC Director | Grant or award · Stock Option (Right to Buy) | +33,150 | 33,150 | ||
| 2025-07-14 | SIEGALL CLAY B Director | Grant or award · Stock Option (Right to Buy) | +33,150 | 33,150 | ||
| 2025-07-14 | Sasser Amy Kate Director | Grant or award · Stock Option (Right to Buy) | +33,150 | 33,150 | ||
| 2025-07-14 | Golumbeski George Director | Grant or award · Stock Option (Right to Buy) | +33,150 | 33,150 | ||
| 2025-07-14 | Gibson Neil W Director | Grant or award · Stock Option (Right to Buy) | +33,150 | 33,150 | ||
| 2025-07-14 | Brownstein Carrie Director | Grant or award · Stock Option (Right to Buy) | +33,150 | 33,150 | ||
| 2025-07-14 | Brous Tyler Director | Grant or award · Stock Option (Right to Buy) | +33,150 | 33,150 | ||
| 2025-07-14 | Boudreau Helen M Director | Grant or award · Stock Option (Right to Buy) | +33,150 | 33,150 | ||
| 2025-01-28 | Shukla Abhinav A. Chief Technical Officer | Grant or award · Common Stock | +165,200 | 165,200 | ||
| 2025-01-28 | DeYoung Casi Chief Business Officer | Grant or award · Common Stock | +194,300 | 194,300 | ||
| 2025-01-28 | Pandite Arundathy N. Chief Medical Officer | Grant or award · Common Stock | +206,200 | 206,200 | ||
| 2025-01-28 | Stout Stephen See Remarks | Grant or award · Stock Option (Right to Buy) | +177,000 | 177,000 | ||
| 2025-01-28 | Neill Andrew R Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +214,000 | 214,000 |
Page 5 of 7 · 140 trades